Therapeutically useful substituted hydropyrido [3,2,1-ij] quinoline compounds

Details for Australian Patent Application No. 2009244199 (hide)

Owner Allergan, Inc.

Inventors Bhat, Smita; Donello, John E.; Chow, Ken; Garst, Michael E.; Beard, Richard L.; Sinha, Santosh C.

Agent Davies Collison Cave

Pub. Number AU-A-2009244199

PCT Pub. Number WO2009/137681

Priority 12/433,978 01.05.09 US; 61/051,533 08.05.08 US

Filing date 7 May 2009

Wipo publication date 12 November 2009

International Classifications

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/4745 (2006.01)

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 27/00 (2006.01) Drugs for disorders of the senses

C07D 471/06 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

C07D 471/16 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

Event Publications

4 August 2011 Section 223 Application Received

  Sinha, Santosh C.; Beard, Richard L.; Chow, Ken; Garst, Michael E.; Allergan, Inc.; Donello, John E.; Bhat, Smita An application to extend the time from 08 Dec 2010 to 08 Jun 2011 in which to enter the National Phase has been filed . Address for service in Australia - Davies Collison Cave Level 14 255 Elizabeth Street Sydney NSW 2000

22 September 2011 Section 223 Application Allowed

  Sinha, Santosh C.; Beard, Richard L.; Chow, Ken; Garst, Michael E.; Allergan, Inc.; Donello, John E.; Bhat, Smita The time in which to enter the National Phase has been extended to 08 Jun 2011. Address for service in Australia - Davies Collison Cave Level 14 255 Elizabeth Street Sydney NSW 2000

6 October 2011 PCT application entered the National Phase

  PCT publication WO2009/137681 Priority application(s): WO2009/137681

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009244200-Medical failure pattern search engine

2009244197-3-hydroxy gepirone for the treatment of attention deficit disorder and sexual dysfunction